German surgeon's fraud prompts sickness fund probe
This article was originally published in Clinica
Fears of a nationwide witch-hunt have surfaced in Germany after the Lower Saxony office of Germany's largest sickness fund, the AOK, and several other statutory health insurance funds, agreed to repay 4,036 fund members between Euro250-350 ($218-262) each as a result of false accounting by a Luneburg surgeon. This is the first time such as repayment has happened.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.